-
Efforts to achieve "virtual elimination" of new HIV infections in infants by 2015 could prove highly challenging according to computer modelling of the situation in Zimbabwe, one of the most seriously HIV-affected countries in southern Africa.Using
a ...
11 January 2012 | Carole Leach-Lemens
-
Use
of nevirapine with cotrimoxazole prophylaxis in HIV-exposed uninfected infants
(HIV-EU) until six months of age in Zimbabwe
and Uganda
was safe with no immediate or long-term adverse effects, researchers on behalf
of the HIV Prevention Trials Network (HPTN) 046 protocol ...
15 December 2011 | Carole Leach-Lemens
-
Early
weaning resulted in almost twice as many acute illnesses and hospitalisations
among HIV-exposed uninfected infants when compared to infants who continued to
be breastfed beyond six months of age, long-term follow-up of the PEPI-Malawi
study of extended infant antiretroviral ...
19 August 2011 | Carole Leach-Lemens
-
Cotrimoxazole
prophylaxis may not provide significant protection against bacterial infections
in HIV-exposed but uninfected infants, and may even undermine the health benefits of
breastfeeding, according to research from South Africa.
Optimal
use of cotrimoxazole prophylaxis (CTXP) in breastfed HIV-exposed negative
infants in ...
09 August 2011 | Carole Leach-Lemens
-
Valaciclovir
used to suppress herpes simplex virus 2 (HSV-2) in HIV co-infected pregnant and
post-partum women in Nairobi, Kenya, slowed HIV disease progression and reduced
viral load in breast milk, according to researchers from the Universities of
Washington, Nairobi and ...
26 July 2011 | Carole Leach-Lemens
-
Extended use of nevirapine or
zidovudine and nevirapine in infants can reduce the risks of HIV transmission
through breastmilk by over 70%, Charles van der Horst reported in a late
breaker session at the International AIDS Society conference
(IAS 2011) ...
25 July 2011 | Carole Leach-Lemens
-
Nine years after the start of a national prevention of
mother-to-child transmission (PMTCT) programme, South Africa’s mother-to-child
HIV transmission (MTCT) rate is under 4%
at four to eight weeks after birth, according to South Africa’s first national
PMTCT impact evaluation. ...
19 July 2011 | Carole Leach-Lemens
-
Two
thirds of breastfeeding infants infected after birth, born to mothers on
antiretroviral therapy (ART), developed resistance to one or more
antiretroviral drugs according to Clement Zeh and colleagues in a secondary
analysis of the Kisumu Breastfeeding Study (KiBS) published ...
31 March 2011 | Carole Leach-Lemens
-
One
in nine HIV-infected children with advanced illness was hospitalised with
severe malnutrition within 12 weeks of starting antiretroviral and these
children had a 15-fold increased risk of dying within the first six months
compared to those children not hospitalised, ...
29 March 2011 | Carole Leach-Lemens
-
Extending the use of daily infant nevirapine to six months reduced the risk of
breastfeeding mother-to-child transmission by a significant 76% in
HIV-positive mothers with CD4 cell counts over 350 and not yet
eligible for antiretroviral treatment Yvonne Maldonado ...
07 March 2011 | Carole Leach-Lemens
Talking points: a checklist for you and your doctorTalking points is designed to help you talk to your doctor about HIV
treatment.
Preventing HIVAn essential resource providing evidence-based information on preventing HIV infection. 
A visit from Wandsworth Oasis26 January 2012On Wednesday this
week, we were delighted to have a visit...
Adventurers with HIV – a photo gallery19 January 2012Back in
November we sent out a
call for adventurous people with...
We’d like to introduce a friend of ours…12 January 2012...